News
We recently published 10 Shares Explode as Earnings Impress. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the ...
IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...
LinkGevity is among a cluster of biotech firms in Cambridge working on potential longevity treatments. They include clock.bio ...
John Burke, MD, discusses his editor-in-chief column from the July 2025 issue of Targeted Therapies in Oncology.
Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...
July 25, 2025 - Government and private funding for genomic research is the key factor driving market revenue growth. According to the Alzheimer’s Dis ...
Would you dab perfume on a six-month-old? Paint their tiny nails with polish that contains formaldehyde? Dust bronzer onto their cheeks? An ...
Tumors of the central nervous system (CNS) are the most common pediatric tumor type and the leading cause of cancer-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results